Business Description
This fund tracks a group of biotech and pharmaceutical companies listed on the Nasdaq exchange. It uses borrowed capital to amplify returns, putting at least 80% of its assets into index holdings or comparable investments. Because it focuses on a narrow segment of the market, it carries higher concentration risk than a broadly diversified fund.
